Skip to main content

MoneyWorks4Me

Sanjivani Paranteral informs about disclosures

20 Aug 2021 Evaluate

Sanjivani Paranteral has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashwani Khemka.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1817.60
Dr. Reddys Labs. 1363.95
Cipla 1397.70
Lupin 1977.45
Zydus Lifesciences 1188.85
View more..